29
Views
39
CrossRef citations to date
0
Altmetric
Article

Rev7/MAD2B Links c-Jun N-Terminal Protein Kinase Pathway Signaling to Activation of the Transcription Factor Elk-1

, &
Pages 2861-2869 | Received 06 Dec 2006, Accepted 02 Feb 2007, Published online: 27 Mar 2023

REFERENCES

  • Buchwalter, G., C. Gross, and B. Wasylyk. 2004. Ets ternary complex transcription factors. Gene 324:1–14.
  • Chang, L., and M. Karin. 2001. Mammalian MAP kinase signalling cascades. Nature 410:37–40.
  • Chen, J., and G. Fang. 2001. MAD2B is an inhibitor of the anaphase-promoting complex. Genes Dev. 15:1765–1770.
  • Cruzalegui, F. H., E. Cano, and R. Treisman. 1999. ERK activation induces phosphorylation of Elk-1 at multiple S/T-P motifs to high stoichiometry. Oncogene 18:7948–7957.
  • Derijard, B., M. Hibi, I. H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and R. J. Davis. 1994. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025–1037.
  • Edmunds, J. W., and L. C. Mahadevan. 2004. MAP kinases as structural adaptors and enzymatic activators in transcription complexes. J. Cell Sci. 117:3715–3723.
  • Gille, H., T. Strahl, and P. E. Shaw. 1995. Activation of ternary complex factor Elk-1 by stress-activated protein kinases. Curr. Biol. 5:1191–1200.
  • Jacobs, D., D. Glossip, H. Xing, A. J. Muslin, and K. Kornfeld. 1999. Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. Genes Dev. 13:163–175.
  • Kyriakis, J. M., and J. Avruch. 2001. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81:807–869.
  • Liu, Y., M. Gorospe, C. Yang, and N. J. Holbrook. 1995. Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. Inhibition of c-Jun N-terminal kinase activity and AP-1-dependent gene activation. J. Biol. Chem. 270:8377–8380.
  • Murakumo, Y. 2002. The property of DNA polymerase zeta: REV7 is a putative protein involved in translesion DNA synthesis and cell cycle control. Mutat. Res. 510:37–44.
  • Murakumo, Y., S. Mizutani, M. Yamaguchi, M. Ichihara, and M. Takahashi. 2006. Analyses of ultraviolet-induced focus formation of hREV1 protein. Genes Cells 11:193–205.
  • Murakumo, Y., Y. Ogura, H. Ishii, S. Numata, M. Ichihara, C. M. Croce, R. Fishel, and M. Takahashi. 2001. Interactions in the error-prone postreplication repair proteins hREV1, hREV3, and hREV7. J. Biol. Chem. 276:35644–35651.
  • Pfleger, C. M., E. Lee, and M. W. Kirschner. 2001. Substrate recognition by the Cdc20 and Cdh1 components of the anaphase-promoting complex. Genes Dev. 15:2396–2407.
  • Quinones, A., K. U. Dobberstein, and N. G. Rainov. 2003. The egr-1 gene is induced by DNA-damaging agents and non-genotoxic drugs in both normal and neoplastic human cells. Life Sci. 72:2975–2992.
  • Roux, P. P., and J. Blenis. 2004. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68:320–344.
  • Sharrocks, A. D. 2002. Complexities in ETS-domain transcription factor function and regulation: lessons from the TCF subfamily. Biochem. Soc. Trans. 30:1–9.
  • Shaw, P. E., and J. Saxton. 2003. Ternary complex factors: prime nuclear targets for mitogen-activated protein kinases. Int. J. Biochem. Cell Biol. 35:1210–1226.
  • Shore, P., and A. D. Sharrocks. 1994. The transcription factors Elk-1 and serum response factor interact by direct protein-protein contacts mediated by a short region of Elk-1. Mol. Cell. Biol. 14:3283–3291.
  • Sonoda, E., T. Okada, G. Y. Zhao, S. Tateishi, K. Araki, M. Yamaizumi, T. Yagi, N. S. Verkaik, D. C. van Gent, M. Takata, and S. Takeda. 2003. Multiple roles of Rev3, the catalytic subunit of polzeta in maintaining genome stability in vertebrates. EMBO J. 22:3188–3197.
  • Wassmann, K., V. Liberal, and R. Benezra. 2003. Mad2 phosphorylation regulates its association with Mad1 and the APC/C. EMBO J. 22:797–806.
  • Whitmarsh, A. J. 2006. The JIP family of MAPK scaffold proteins. Biochem. Soc. Trans. 34:828–832.
  • Whitmarsh, A. J., P. Shore, A. D. Sharrocks, and R. J. Davis. 1995. Integration of MAP kinase signal transduction pathways at the serum response element. Science 269:403–407.
  • Yang, S. H., D. C. Bumpass, N. D. Perkins, and A. D. Sharrocks. 2002. The ETS domain transcription factor Elk-1 contains a novel class of repression domain. Mol. Cell. Biol. 22:5036–5046.
  • Yang, S. H., and A. D. Sharrocks. 2005. PIASx acts as an Elk-1 coactivator by facilitating derepression. EMBO J. 24:2161–2171.
  • Yang, S. H., and A. D. Sharrocks. 2006. PIASxalpha differentially regulates the amplitudes of transcriptional responses following activation of the ERK and p38 MAPK pathways. Mol. Cell 22:477–487.
  • Yang, S. H., A. D. Sharrocks, and A. J. Whitmarsh. 2003. Transcriptional regulation by the MAP kinase signaling cascades. Gene 320:3–21.
  • Yang, S. H., P. Shore, N. Willingham, J. H. Lakey, and A. D. Sharrocks. 1999. The mechanism of phosphorylation-inducible activation of the ETS-domain transcription factor Elk-1. EMBO J. 18:5666–5674.
  • Yang, S. H., E. Vickers, A. Brehm, T. Kouzarides, and A. D. Sharrocks. 2001. Temporal recruitment of the mSin3A-histone deacetylase corepressor complex to the ETS domain transcription factor Elk-1. Mol. Cell. Biol. 21:2802–2814.
  • Yang, S. H., A. J. Whitmarsh, R. J. Davis, and A. D. Sharrocks. 1998. Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1. EMBO J. 17:1740–1749.
  • Yang, S. H., P. R. Yates, A. J. Whitmarsh, R. J. Davis, and A. D. Sharrocks. 1998. The Elk-1 ETS-domain transcription factor contains a MAP kinase targeting motif. Mol. Cell. Biol. 18:710–720.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.